Ausschreibungen Universitätsprofessuren

Die Universitätsmedizin Göttingen (UMG) verfolgt im Rahmen ihrer strategischen Planung die konsequente Weiterentwicklung ihrer profilbildenden Forschungsschwerpunkte Neurowissenschaften, Herz-Kreislauf-Medizin und Onkologie mit translationalen Ansätzen u.a. als Partnerstandort der Gesundheitsforschungszentren Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) und Deutsches Zentrum für Kinder- und Jugendgesundheit (DZKJ). Die UMG ist auf dem Göttingen Campus eng vernetzt mit den natur- und biowissenschaftlichen Einrichtungen der Universität sowie den außeruniversitären Einrichtungen am Standort.

In der Klinik für Kinder- und Jugendmedizin (Direktorin Prof. Dr. J. Gärtner) der UMG ist eine

Universitätsprofessur

Sozialpädiatrie

(Bes. Gr. W3)

verbunden mit der Leitung des Sozialpädiatrischen Zentrums sowie des Zentrums für Seltene Erkrankungen Göttingen (ZSEG) zum nächstmöglichen Zeitpunkt auf Dauer zu besetzen.

Die Professur vertritt den Bereich Sozialpädiatrie in Forschung, Lehre und Krankenversorgung. Die Bewerberin / der Bewerber sollte über ein herausragendes wissenschaftliches Profil und sehr gute klinische Kenntnisse auf den Gebieten der Neuropädiatrie und Sozialpädiatrie verfügen. Die Professur mit ihrem Forschungsprofil sollte im Rahmen des Schwerpunkts Neurowissenschaften der Universitätsmedizin Göttingen und der im Deutschen Zentrum für Kinder- und Jugendgesundheit (DZKJ) bestehenden Forschungsgebiete anschlussfähig sein.

Die Anerkennung als Fachärztin / Facharzt für Kinder- und Jugendmedizin mit Schwerpunkt Neuropädiatrie, die Habilitation oder gleichwertige wissenschaftliche Leistungen, ein eigenständiges wissenschaftliches Profil mit entsprechenden Publikationsleistung und kompetitiv eingeworbenen Drittmitteln sowie pädagogische Eignung und ein hohes Engagement in der Lehre und in der Betreuung des wissenschaftlichen Nachwuchses werden ebenso wie die Bereitschaft zur Mitwirkung an der akademischen Selbstverwaltung vorausgesetzt.

Die weiteren Einstellungsvoraussetzungen für Professorinnen und Professoren ergeben sich aus § 25 des Niedersächsischen Hochschulgesetzes in der zurzeit geltenden Fassung. Die UMG besitzt das Berufungsrecht.

Die Einstellung von Professorinnen und Professoren mit ärztlichen Aufgaben erfolgt im Rahmen außertariflicher Verträge mit Grundvergütung sowie leistungsabhängigen Vergütungsbestandteilen.

Die UMG strebt eine Erhöhung des Frauenanteils an und fordert daher qualifizierte Frauen ausdrücklich zur Bewerbung auf. Schwerbehinderte werden bei entsprechender Eignung bevorzugt berücksichtigt.

Bitte reichen Sie Ihre Bewerbungsunterlagen bis spätestens 16.09.2024 online über folgenden Link ein: http://go.umg.eu/berufungen

Bei Fragen stehen wir unter Berufungen(at)med.uni-goettingen.de gerne zur Verfügung.

As part of its strategic planning, the University Medical Center Göttingen (UMG) is pursuing the consistent development of its priority research areas in neuroscience, cardiovascular medicine, oncology and molecular cell biology with translational approaches, among others, within the new Else Kröner Fresenius Center for Optogenetic Therapies. On the Göttingen Campus, UMG is closely linked to the natural and life science institutions of the University as well as the non-university institutions.

As part of the Else Kröner Fresenius Center for Optogenetic Therapies, a

W2 professorship (tenured) (f/m/d)

Translational Otology

is to be filled at the earliest possible date.

The Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ) is a new clinical research center of the UMG with partners at the Göttingen Campus as well as at Medical University of Hannover, Technical University of Chemnitz, and University of Freiburg. The goal of EKFZ is the development and clinical translation of optogenetic therapies for the deaf and the blind as well as development of optogenetic gastric pacemakers and brain computer interfaces.

We are looking for a highly qualified, internationally visible clinician scientist with an independent scientific profile as well as comprehensive knowledge and experience in the field of ear, nose and throat medicine that qualifies for taking on a clinical management position. We especially welcome applications of clinician scientists with track in clinical translation and experience in the field of experimental otology. A focus on inner ear research will be desirable as well as. experience in the fields of animal experiments, basic electrophysiological research, and optical measurements of cellular activity in the auditory and vestibular organs is desirable. The applicant is expected to advance the clinical translation of optogenetic hearing rehabilitation as part of the Deptartment of Otorhinolaryngology in collaboration with the EKFZ teams and platforms. We are looking for a clinicial researcher who will pursue further methodological development through collaborative use of the infrastructure available at the Göttingen Campus and make a substantial contribution to the acquisition of competitive third-party funding, the promotion of young scientists, and the development of teaching in biomedicine and life sciences. An interdisciplinary research environment provided by the participating institutions of the EKFZ is guaranteed.

A habilitation or an equivalent scientific qualification is required, as well as teaching experience. Further requirements for the appointment of university professors are laid out in the current version of § 25 of the Higher Education Act of the State of Lower Saxony (Niedersächsisches Hochschulgesetz-NHG). The UMG reserves the right of appointment.

Applications from scientists from abroad are explicitly welcome.

UMG aims to increase the proportion of women and therefore explicitly invites qualified women to apply. Severely disabled persons will be given preferential consideration if they have the same qualifications.

Please submit your application documents online via the following link by 31.08.2024 at the latest:

http://go.umg.eu/berufungen

For further information on the research profile of the EKFZ, please contact Prof. Dr. Tobias Moser (designated EKFZ spokesperson, tmoser(at)gwdg.de), Head of the Institute for Auditory Neuroscience.

If you have any questions, please do not hesitate to contact us at berufungen(at)med.uni-goettingen.de.

As part of its strategic planning, the University Medical Center Göttingen (UMG) is pursuing the consistent development of its priority research areas in neuroscience, cardiovascular medicine, oncology and molecular cell biology with translational approaches, among others, within the new Else Kröner Fresenius Center for Optogenetic Therapies. On the Göttingen Campus, UMG is closely linked to the natural and life science institutions of the University as well as the non-university institutions.

As part of the Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ) at UMG, a

W2 professorship (tenured) (f/m/d)

Disease Modelling

is to be filled at the earliest possible date.

The Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ) is a new interdisciplinary clinical research center of the UMG with partners at the Göttingen Campus as well as at Medical University of Hannover, Technical University of Chemnitz, and University of Freiburg. The goal of EKFZ is the development and clinical translation of optogenetic therapies for the deaf and the blind as well as development of optogenetic gastric pacemakers and brain computer interfaces.

The position is associated with setting up and leading the Disease Modelling platform of EKFZ in collaboration with the other platforms and teams of EKFZ. We are looking for a highly qualified, internationally visible scientist with an independent scientific profile as well as comprehensive knowledge and many years of experience in the development and characterization of cell- and tissue-based disease models and tools for regenerative medicine. Practical experience in the production of cell and organoid models of human diseases derived from induced pluripotent stem cells, in their molecular and physiological characterization, as well as experience in multidisciplinary cooperation for the application and characterization of disease models in preclinical studies are required. We are looking for a researcher who will pursue further methodological development through collaborative use of the infrastructure available at the Göttingen Campus and make a substantial contribution to the acquisition of competitive third-party funding, the promotion of young scientists and the development of teaching in biomedicine and life sciences. An interdisciplinary research environment provided by the participating institutions of the EKFZ is guaranteed.

A habilitation or an equivalent scientific qualification is required, as well as teaching experience. Further requirements for the appointment of university professors are laid out in the current version of § 25 of the Higher Education Act of the State of Lower Saxony (Niedersächsisches Hochschulgesetz). The UMG reserves the right of appointment.

Applications from scientists from abroad are explicitly welcome.

UMG aims to increase the proportion of women and therefore explicitly invites qualified women to apply. Severely disabled persons will be given preferential consideration if they have the same qualifications. Please submit your application documents online via the following link by 31.08.2024 at the latest: http://go.umg.eu/berufungen

For further information on the research profile of the EKFZ, please contact Prof. Dr. Tobias Moser (designated EKFZ spokesperson, tmoser(at)gwdg.de), Head of the Institute for Auditory Neuroscience.

If you have any questions, please do not hesitate to contact us at Berufungen(at)med.uni-goettingen.de.

As part of its strategic planning, the University Medical Center Göttingen (UMG) is pursuing the consistent development of its priority research areas in neuroscience, cardiovascular medicine, oncology and molecular cell biology with translational approaches, among others, within the new Else Kröner Fresenius Center for Optogenetic Therapies. On the Göttingen Campus, UMG is closely linked to the natural and life science institutions of the University as well as the non-university institutions.

As part of the Else Kröner Fresenius Center for Optogenetic Therapies, a

W2 professorship (tenured) (f/m/d)

Translational Ophthalmology

is to be filled at the earliest possible date.

The Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ) is a new interdisciplinary clinical research center of the UMG with partners at the Göttingen Campus as well as at Medical University of Hannover, Technical University of Chemnitz, and University of Freiburg. The goal of EKFZ is the development and clinical translation of optogenetic therapies for the deaf and the blind as well as development of optogenetic gastric pacemakers and brain computer interfaces.

We are looking for a highly qualified, internationally visible clinician scientist with an independent scientific profile as well as comprehensive knowledge and experience in retinal dystrophies and/or in the field of gene therapeutic restoration of vision that qualify you to take on a leading clinical and research position. We especially welcome applications of clinician scientists with track in clinical translation. Experience in the fields of animal experiments, basic electrophysiological research, and optical measurements of cellular activity in the retina as well as in the implementation of early clinical trials including diagnostic low vision tests and visual rehabilitation is desirable. The applicant is expected to contribute preclinically in the field of optogenetic applications and to advance the clinical translation of optogenetic vision restoration as part of the Deptartment of Ophthalmology and in collaboration with other EKFZ teams and platforms. We are looking for a clinical researcher who will pursue further methodological development through collaborative use of the infrastructure available at the Göttingen Campus and make a substantial contribution to the acquisition of competitive third-party funding, the promotion of young scientists, and the development of teaching in medicine, biomedicine, and life sciences. An interdisciplinary research environment provided by the participating institutions of the EKFZ is guaranteed.

A habilitation or an equivalent scientific qualification is required, as well as teaching experience. Further requirements for the appointment of university professors are laid out in the current version of § 25 of the Higher Education Act of the State of Lower Saxony (Niedersächsisches Hochschulgesetz - NHG). The UMG reserves the right of appointment.

Applications from scientists from abroad are explicitly welcome and the holder of the position would be integrated in an international team.

UMG aims to increase the proportion of women and therefore explicitly invites qualified women to apply. Severely disabled persons will be given preferential consideration if they have the same qualifications.

Please submit your application documents online via the following link by 31.08.2024 at the latest:

http://go.umg.eu/berufungen

For further information on the research profile of the EKFZ, please contact Prof. Dr. Tobias Moser (designated EKFZ spokesperson, tmoser(at)gwdg.de), Head of the Institute for Auditory Neuroscience.

If you have any questions, please do not hesitate to contact us at Berufungen(at)med.uni-goettingen.de.

As part of its strategic planning, the University Medical Center Göttingen (UMG) is pursuing the consistent development of its priority research areas in neuroscience, cardiovascular medicine, oncology and molecular cell biology with translational approaches, among others, within the new Else Kröner Fresenius Center for Optogenetic Therapies. On the Göttingen Campus, UMG is closely linked to the natural and life science institutions of the University as well as the non-university institutions.

As part of the Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ) at UMG, a

W2 professorship with tenure track option (f/m/d)

Opsin Engineering

is to be filled at the earliest possible date. The appointment is initially for a period of five years and will become permanent upon positive tenure evaluation in the fifth year.

The Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ) is a new interdisciplinary clinical research center of the UMG with partners at the Göttingen Campus as well as at Medical University of Hannover, Technical University of Chemnitz, and University of Freiburg. The goal of EKFZ is the development and clinical translation of optogenetic therapies for the deaf and the blind as well as development of optogenetic gastric pacemakers and brain computer interfaces.

The position is associated with setting up and leading the Opsin Engineering platform of EKFZ in collaboration with the other platforms and teams of EKFZ. We are looking for a highly qualified, internationally visible scientist with an independent scientific profile as well as extensive knowledge and many years of experience in the development of molecular optogenetic tools (opsins), their biophysical characterization and preparation of their use for biomedical applications, in particular future optogenetic therapies. Practical experience in the rational design of new opsin variants, the bioinformatic analysis of candidate genes and high-throughput characterization of opsin variants, as well as experience with multidisciplinary cooperation for the application and characterization of the developed opsins in preclinical studies are required. We are looking for a researcher who will pursue further methodological development through collaborative use of the infrastructure available at the Göttingen Campus and make a substantial contribution to the acquisition of competitive third-party funding, the promotion of young scientists and the development of teaching in biomedicine and life sciences. An interdisciplinary research environment provided by the participating institutions of the EKFZ is guaranteed.

A habilitation or an equivalent scientific qualification is required, as well as teaching experience. Further requirements for the appointment of university professors are laid out in the current version of § 25 of the Higher Education Act of the State of Lower Saxony (Niedersächsisches Hochschulgesetz). The UMG reserves the right of appointment.

Applications from scientists from abroad are explicitly welcome.

UMG aims to increase the proportion of women and therefore explicitly invites qualified women to apply. Severely disabled persons will be given preferential consideration if they have the same qualifications.

Please submit your application documents online via the following link by 31.08.2024 at the latest:

http://go.umg.eu/berufungen

For further information on the research profile of the EKFZ, please contact Prof. Dr. Tobias Moser (designated EKFZ spokesperson, tmoser(at)gwdg.de), Head of the Institute for Auditory Neuroscience.

If you have any questions, please do not hesitate to contact us at Berufungen(at)med.uni-goettingen.de.